[EN] CIS-2,4,5- TRIPHENYL-IMIDAZOLINES AND THEIR USE IN THE TREATMENT OF TUMORS<br/>[FR] CIS-2,4,5- TRIPHENYL-IMIDAZOLINES ET LEURS UTILISATIONS DANS LE TRAITEMENT DES TUMEURS
申请人:HOFFMANN LA ROCHE
公开号:WO2003051359A1
公开(公告)日:2003-06-26
The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts ad esters thereof, having the designations provides herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity. Formula (I).
The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.
1
CIS-2,4,5- TRIPHENYL-IMIDAZOLINES AND THEIR USE IN THE TREATMENT OF TUMORS
申请人:F.HOFFMANN-LA ROCHE AG
公开号:EP1458380A1
公开(公告)日:2004-09-22
US6734302B2
申请人:——
公开号:US6734302B2
公开(公告)日:2004-05-11
Cis-imidazolines
申请人:——
公开号:US20030153580A1
公开(公告)日:2003-08-14
The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.
1